KR20080038416A - 수면제와 치환된 비스 아릴 및 헤테로아릴 화합물의 배합물및 이의 치료요법적 용도 - Google Patents

수면제와 치환된 비스 아릴 및 헤테로아릴 화합물의 배합물및 이의 치료요법적 용도 Download PDF

Info

Publication number
KR20080038416A
KR20080038416A KR1020087006619A KR20087006619A KR20080038416A KR 20080038416 A KR20080038416 A KR 20080038416A KR 1020087006619 A KR1020087006619 A KR 1020087006619A KR 20087006619 A KR20087006619 A KR 20087006619A KR 20080038416 A KR20080038416 A KR 20080038416A
Authority
KR
South Korea
Prior art keywords
alkyl
formula
compound
sleep
fluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020087006619A
Other languages
English (en)
Korean (ko)
Inventor
게리 티 에몬스
사타파나 콩사무트
크레그 엔 칼슨
코린 엠. 레고프
Original Assignee
아벤티스 파마슈티칼스 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아벤티스 파마슈티칼스 인크. filed Critical 아벤티스 파마슈티칼스 인크.
Publication of KR20080038416A publication Critical patent/KR20080038416A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
KR1020087006619A 2005-08-19 2006-08-16 수면제와 치환된 비스 아릴 및 헤테로아릴 화합물의 배합물및 이의 치료요법적 용도 Withdrawn KR20080038416A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70965505P 2005-08-19 2005-08-19
US60/709,655 2005-08-19

Publications (1)

Publication Number Publication Date
KR20080038416A true KR20080038416A (ko) 2008-05-06

Family

ID=37772166

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020087006619A Withdrawn KR20080038416A (ko) 2005-08-19 2006-08-16 수면제와 치환된 비스 아릴 및 헤테로아릴 화합물의 배합물및 이의 치료요법적 용도

Country Status (17)

Country Link
US (1) US7618650B2 (cg-RX-API-DMAC7.html)
EP (1) EP1928442B1 (cg-RX-API-DMAC7.html)
JP (1) JP2009504761A (cg-RX-API-DMAC7.html)
KR (1) KR20080038416A (cg-RX-API-DMAC7.html)
CN (1) CN101242819A (cg-RX-API-DMAC7.html)
AR (1) AR055609A1 (cg-RX-API-DMAC7.html)
AT (1) ATE447400T1 (cg-RX-API-DMAC7.html)
AU (1) AU2006283703A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0614943A2 (cg-RX-API-DMAC7.html)
CA (1) CA2617980A1 (cg-RX-API-DMAC7.html)
DE (1) DE602006010219D1 (cg-RX-API-DMAC7.html)
ES (1) ES2336142T3 (cg-RX-API-DMAC7.html)
MX (1) MX2008001778A (cg-RX-API-DMAC7.html)
RU (1) RU2008110498A (cg-RX-API-DMAC7.html)
SG (1) SG140147A1 (cg-RX-API-DMAC7.html)
TW (1) TW200815009A (cg-RX-API-DMAC7.html)
WO (1) WO2007024600A2 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2889811B1 (fr) * 2005-08-19 2009-10-09 Sanofi Aventis Sa Association d'un agent hypnotique a duree d'action longue et d'un agent hypnotique a duree d'action courte, composition pharmaceutique la contenant et son application en therapeutique.
BRPI0520797B8 (pt) * 2005-11-18 2021-05-25 Accu Break Tech Inc forma de dosagem farmacêutica comprimida em bicamadas
WO2010045190A1 (en) 2008-10-15 2010-04-22 Boehringer Ingelheim International Gmbh Fused heteroaryl diamide compounds useful as mmp-13 inhibitors
EP2340243B1 (en) 2008-10-17 2014-10-08 Boehringer Ingelheim International GmbH Heteroaryl substituted indole compounds useful as mmp-13 inhibitors
CN102018681A (zh) * 2010-12-10 2011-04-20 荣港生技医药科技(北京)有限公司 一种美乐托宁缓释剂、其制备方法及其应用
US20130060052A1 (en) * 2011-01-17 2013-03-07 Takeda Pharmaceutical Company Limited Orally dispersible tablet
CA2903394C (en) 2013-03-14 2021-08-31 Epizyme, Inc. Arginine methyltransferase inhibitors and uses thereof
US9120757B2 (en) 2013-03-14 2015-09-01 Epizyme, Inc. Arginine methyltransferase inhibitors and uses thereof
JP7792730B2 (ja) * 2022-04-27 2025-12-26 杭州新元素▲薬▼▲業▼有限公司 尿酸を降下させるために使用できる化合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU726447B2 (en) * 1996-10-21 2000-11-09 Neurosearch A/S 1-phenyl-benzimidazole compounds and their use as BAGA-A receptor modulators
US20040258750A1 (en) * 1999-06-28 2004-12-23 Gerard Alaux Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
IL152411A0 (en) * 2000-04-24 2003-05-29 Teva Pharma Zolpidem hemitartrate
GT200600042A (es) * 2005-02-10 2006-09-27 Aventis Pharma Inc Compuestos de bis arilo y heteroarilo sustituido como antagonistas selectivos de 5ht2a

Also Published As

Publication number Publication date
EP1928442A2 (en) 2008-06-11
CA2617980A1 (en) 2007-03-01
ATE447400T1 (de) 2009-11-15
RU2008110498A (ru) 2009-09-27
ES2336142T3 (es) 2010-04-08
MX2008001778A (es) 2008-04-07
US7618650B2 (en) 2009-11-17
SG140147A1 (en) 2008-03-28
US20080138413A1 (en) 2008-06-12
WO2007024600A2 (en) 2007-03-01
EP1928442B1 (en) 2009-11-04
CN101242819A (zh) 2008-08-13
TW200815009A (en) 2008-04-01
DE602006010219D1 (de) 2009-12-17
AR055609A1 (es) 2007-08-29
AU2006283703A1 (en) 2007-03-01
BRPI0614943A2 (pt) 2011-04-26
JP2009504761A (ja) 2009-02-05
WO2007024600A3 (en) 2007-05-24

Similar Documents

Publication Publication Date Title
JP5419355B2 (ja) 選択的な5ht2aアンタゴニストとしての置換されたビスアリールおよびヘテロアリール化合物
US7618650B2 (en) Combination of a hypnotic agent and substituted bis aryl and heteroaryl compound and therapeutic application thereof
JP5998133B2 (ja) 二環式アセチル−coaカルボキシラーゼ阻害剤およびそれらの使用
CN115335043A (zh) Pgdh抑制剂以及制备和使用方法
JP2002524512A (ja) cGMPホスホジエステラーゼの縮合ピリジン阻害剤
KR20190014505A (ko) 이소퀴놀린-3-일 카르복스아마이드 및 이의 제제와 용도
AU2017258187A1 (en) Isoquinolin-3-yl carboxamides and preparation and use thereof
KR20180088462A (ko) 수면-관련 호흡기 장애의 치료를 위한 TASK-1 및 TASK-2 채널의 차단제로서의 2-페닐-3-(피페라지노메틸)이미다조[1,2-a]피리딘 유도체
JP2002517445A (ja) cGMPホスホジエステラーゼのキナゾリノン抑制剤
KR20140097459A (ko) 신규 트리플루오로메틸-옥사디아졸 유도체 및 질환의 치료에서의 그의 용도
JP2002540102A (ja) cGMPホスホジエステラーゼの縮合ピリドピリダジン阻害剤
US10744128B2 (en) 6-(5-membered heteroaryl)isoquinolin-3-yl-(5-membered heteroaryl) carboxamides and preparation and use thereof
JP2007517800A (ja) 糖尿病および肥満を処置するためのグリコーゲンホスホリラーゼインヒビターとしての(3−オキソ−3,4−ジヒドロ−キノキサリン−2−イル−アミノ)−ベンズアミド誘導体および関連化合物
FR2952934A1 (fr) Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
CN111542529A (zh) 对蛋白激酶具有抑制活性的噻吩并[3,2-d]嘧啶化合物
HK1121673A (en) Combination of a hypnotic agent and substituted bis aryl and heteroaryl compound and therapeutic application thereof
CN107753486A (zh) 含1,6‑二取代吲哚化合物的低抗药性低副作用慢性骨髓性白血病治疗剂
WO2006102363A1 (en) Methods for treating or preventing acute myelogenous leukemia
RU2775505C2 (ru) Изохинолин-3-иловые карбоксамиды и их получение и применение
CA2617975A1 (en) Combination of a hypnotic agent and r(+)-alpha-(2,3-dimethoxy-phenyl)-1-[2-(4-fluorophenl)ethyl]-4-piperidinemethanol and therapeutic application thereof
HK1231851B (en) Substituted piperidinyl-tetrahydroquinolines and their use as alpha-2c adrenoreceptor antagonists
HK1183307A1 (zh) 作为alk5和/或alk4抑制剂的2-吡啶基取代的咪唑

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20080318

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid